Skip to main content

Advertisement

ADVERTISEMENT

Exclusives

News
01/15/2024
Medline introduces a first-of-its-kind OptiView transparent wound dressing to aid in pressure injury prevention. The innovative clear design allows caregivers to quickly and easily inspect, monitor, and blanch skin with the dressing in...
Medline introduces a first-of-its-kind OptiView transparent wound dressing to aid in pressure injury prevention. The innovative clear design allows caregivers to quickly and easily inspect, monitor, and blanch skin with the dressing in...
Medline introduces a...
01/15/2024
Wound Care
News
01/15/2024
3M was awarded $34.2MM from the US Army Medical Research Acquisition Activity to develop a range of new solutions for infection prevention, wound management, and wound healing. The program will focus on the treatment of traumatic wounds from...
3M was awarded $34.2MM from the US Army Medical Research Acquisition Activity to develop a range of new solutions for infection prevention, wound management, and wound healing. The program will focus on the treatment of traumatic wounds from...
3M was awarded $34.2MM from the...
01/15/2024
Wound Care
News
01/15/2024
MediWound announces the FDA has accepted for review the supplement to the NexoBrid BLA to include pediatric patients with severe thermal burns. NexoBrid received FDA approval in Dec 2022 for eschar removal in adult burn patients with deep...
MediWound announces the FDA has accepted for review the supplement to the NexoBrid BLA to include pediatric patients with severe thermal burns. NexoBrid received FDA approval in Dec 2022 for eschar removal in adult burn patients with deep...
MediWound announces the FDA has...
01/15/2024
Wound Care
News
01/15/2024
Niterra announced its participation in the $10MM convertible debt financing for Imbed Biosciences. Niterra’s investment was made through the CVC fund jointly operated with Pegasus Tech Ventures. Also included was a strong participation by...
Niterra announced its participation in the $10MM convertible debt financing for Imbed Biosciences. Niterra’s investment was made through the CVC fund jointly operated with Pegasus Tech Ventures. Also included was a strong participation by...
Niterra announced its...
01/15/2024
Wound Care
News
01/15/2024
Reprise Biomedical received 510(k) clearance for MiroTract Wound Matrix, a collagen matrix cut to size that includes a delivery system with an optional introducer set for treatment of wounds.
Reprise Biomedical received 510(k) clearance for MiroTract Wound Matrix, a collagen matrix cut to size that includes a delivery system with an optional introducer set for treatment of wounds.
Reprise Biomedical received...
01/15/2024
Wound Care
News
01/15/2024
A 900-patient meta-analysis of 19 RCTs compared the relative healing effectiveness of different debridement methods for DFUs. The authors reported Enzymatic Debridement was superior to other methods in terms of ulcer healing rate and area...
A 900-patient meta-analysis of 19 RCTs compared the relative healing effectiveness of different debridement methods for DFUs. The authors reported Enzymatic Debridement was superior to other methods in terms of ulcer healing rate and area...
A 900-patient meta-analysis of...
01/15/2024
Wound Care
News
01/05/2024

Kirra Fedyszyn - Associate Digital Editor

Kirra Fedyszyn - Associate Digital Ed...
Wound Care Learning Network would like to acknowledge the outstanding efforts of the award winners at last fall's SAWC conference.
Wound Care Learning Network would like to acknowledge the outstanding efforts of the award winners at last fall's SAWC conference.
Wound Care Learning Network...
01/05/2024
Wound Care
News
01/04/2024
A 90-patient RCT will evaluate the efficacy and safety of antimicrobial peptide PL-5 Topical Spray in patients with mild Infections of DFUs with primary outcome of clinical response w/in 24 hours after therapy. Not yet recruiting; estimated...
A 90-patient RCT will evaluate the efficacy and safety of antimicrobial peptide PL-5 Topical Spray in patients with mild Infections of DFUs with primary outcome of clinical response w/in 24 hours after therapy. Not yet recruiting; estimated...
A 90-patient RCT will evaluate...
01/04/2024
Wound Care
News
01/04/2024
A 60-patient RCT is ongoing in China to compare Prontosan Wound Irrigation Sol’n to normal saline in the treatment of bacterial biofilm in chronic wounds with secondary infections. The primary outcome is rate of bacterial biofilm at 7 days....
A 60-patient RCT is ongoing in China to compare Prontosan Wound Irrigation Sol’n to normal saline in the treatment of bacterial biofilm in chronic wounds with secondary infections. The primary outcome is rate of bacterial biofilm at 7 days....
A 60-patient RCT is ongoing in...
01/04/2024
Wound Care
News
01/04/2024
MediWound secures an additional $6.7MM from US Dept of Defense to advance NexoBrid as a non-surgical field care solution for burn treatment in the US Army. The $14.4MM project will advance the development/production of a new,...
MediWound secures an additional $6.7MM from US Dept of Defense to advance NexoBrid as a non-surgical field care solution for burn treatment in the US Army. The $14.4MM project will advance the development/production of a new,...
MediWound secures an additional...
01/04/2024
Wound Care

Advertisement

Advertisement

Advertisement